SOURCE: Applied NeuroSolutions, Inc.

May 22, 2007 10:38 ET

Applied NeuroSolutions to Discuss Its Therapeutic and Diagnostic Programs in the Multi-Billion Dollar Alzheimer's Field Live on Market News First

VERNON HILLS, IL -- (MARKET WIRE) -- May 22, 2007 -- Applied NeuroSolutions, Inc. (OTCBB: APNS) is pleased to announce that its CEO, Ellen Hoffing, and Founding Scientist, Dr. Peter Davies, will be featured in a live interview with Market News First, an online news broadcast and research group featuring the latest opportunities within the microcap market.

The interview is scheduled for Wednesday, May 23, 2007, at 1:00 PM CDT and will be broadcast live from Market News First's website found at This is an exciting opportunity for Applied NeuroSolutions to reach out to its shareholders and interested parties, so be sure to tune in and watch Ms. Hoffing and Dr. Davies talk about the company's progress and plans for novel therapeutic and diagnostic solutions for Alzheimer's patients.

About Applied NeuroSolutions

Applied NeuroSolutions, Inc. (OTCBB: APNS) is developing, in collaboration with Eli Lilly and Company, novel therapeutic compounds to treat and diagnostics to detect Alzheimer's disease (AD) based on discoveries originating from the Albert Einstein College of Medicine. Applied NeuroSolutions has discovered biomarkers that the company believes will aid in the development of effective AD treatments. Applied NeuroSolutions has also been working on both a cerebrospinal fluid (CSF) test and a blood test to detect AD at a very early stage. The CSF test can already differentiate AD patients from those with other diseases that have similar symptoms. There is currently no FDA approved diagnostic test to detect Alzheimer's disease. Alzheimer's disease currently afflicts over 4.5 million Americans, and 30 million people worldwide. For more information, visit


Market News First is an online, market news provider that brings investors current news on the market. Market News First is the only online, live IPTV web site that brings real market news to investors and features live interaction with companies from the Bulletin Board to NYSE.

Through daily, live interviews, we bring you up to date on all the established companies and inform the investors of the newest opportunities within the market. Market News First offers one-on-one interviews with the presidents and CFOs of companies to deliver answers to the questions that investors may ask and provides them insight into the companies' present condition and future plans.

Stay up to date with MN1 NewsWire "News You Can Trust" at

Contact Information

    Applied NeuroSolutions
    Ellen Hoffing
    President, CEO
    Investor Relations
    Ryan Rauch

    Market News First
    Angela Junell